HOXB9 was also an enabler of multi-organ metastasis of lung adenocarcinoma by activating the WNT/TCF pathway and was also a metastatic promoter of colon cancer and a potential biomarker of bevacizumab therapy [17]. The gene discussed is HOXB9; the disease is colonic neoplasm.